5-Amino-1MQ Storage & Handling for Laboratory Research

Navigating the storage, reconstitution, and handling requirements of small-molecule enzyme inhibitors is critical for preserving molecular integrity during preclinical assays. This technical guide outlines validated laboratory protocols for maintaining 5-Amino-1MQ stability, optimizing solvent reconstitution, and ensuring assay reproducibility.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Navigating the storage, reconstitution, and handling requirements of small-molecule enzyme inhibitors is critical for preserving molecular integrity during preclinical assays. This technical guide outlines validated laboratory protocols for maintaining 5-Amino-1MQ stability, optimizing solvent reconstitution, and ensuring assay reproducibility.

Reviewed by PX1 Research scientific team

Key takeaways

  • 5-Amino-1-methylquinolinium ([5-Amino-1MQ](/research-peptides/5-amino-1mq)) is a selective, membrane-permeable small molecule inhibitor of nicotinamide N-methyltransferase (NNMT).
  • Understanding the baseline physical and chemical attributes of [5-Amino-1MQ](/research-peptides/5-amino-1mq) is necessary for designing appropriate storage and solubilization workflows.
  • To maximize long-term stability and prevent chemical degradation, solid [5-Amino-1MQ](/research-peptides/5-amino-1mq) should be stored in desiccated, climate-controlled environments immediately upon arrival at the research facility.
  • Reconstitution of [5-Amino-1MQ](/research-peptides/5-amino-1mq) requires careful consideration of solvent compatibility, target concentration, and downstream biological assay requirements.

Introduction to 5-Amino-1MQ in Laboratory Settings

5-Amino-1-methylquinolinium (5-Amino-1MQ) is a selective, membrane-permeable small molecule inhibitor of nicotinamide N-methyltransferase (NNMT). In biochemical and cellular research, NNMT serves as a primary cytosolic enzyme catalyzing the methylation of nicotinamide (NAM) using S-adenosylmethionine (SAM) as the methyl donor. By inhibiting NNMT enzymatic activity, researchers can alter fundamental intracellular metabolic flux, preventing the irreversible consumption of nicotinamide and preserving substrates required for the NAD+ salvage pathway.

As a core tool in cellular metabolic research, the 5-Amino-1MQ compound is extensively investigated in vitro and in animal models to elucidate pathways governing cellular energy homeostasis. Preclinical studies suggest that NNMT inhibition directly leads to elevated intracellular NAD+ concentrations, enhanced mitochondrial respiration rates, and favorable shifts in fat-metabolism markers. Maintaining the chemical integrity of 5-Amino-1MQ prior to assay administration is essential for gathering precise, reproducible quantitative data across cell culture and tissue homogenate models.

Physicochemical Properties and Chemical Stability

Understanding the baseline physical and chemical attributes of 5-Amino-1MQ is necessary for designing appropriate storage and solubilization workflows. Structurally, 5-Amino-1MQ exists as a quinolinium salt, typically supplied as a solid, high-purity crystalline or lyophilized powder. The molecule possesses a distinct aromatic framework with an amino substitution at the 5-position, conferring specific ultraviolet-visible (UV-Vis) absorption characteristics and distinct solubility profiles compared to peptide-based research agents.

Unlike standard linear or cyclic peptides susceptible to rapid enzymatic degradation or amide hydrolysis, 5-Amino-1MQ demonstrates superior baseline stability in its dry, solid-state form. However, like many quinolinium derivatives, the molecule remains sensitive to prolonged exposure to ambient moisture, elevated thermal energy, and direct ultraviolet irradiation. Exposure to atmospheric humidity can initiate hygroscopic moisture uptake, leading to weight variations during analytical mass measurements and potential degradation of the active compound over extended timeframes. To review foundational handling concepts for dry reagents, researchers may reference our comprehensive lyophilized peptide storage guide.

Dry Compound Storage Protocols: Temperature and Atmosphere Controls

To maximize long-term stability and prevent chemical degradation, solid 5-Amino-1MQ should be stored in desiccated, climate-controlled environments immediately upon arrival at the research facility. For long-term archiving exceeding 30 days, the dry powder must be held at reduced temperatures, ideally between -20°C and -80°C. Under these ultra-low temperature conditions, oxidative pathways and ambient chemical degradation are virtually halted, preserving compound purity above 98% for extended operational periods.

For short-term working stock stored for under four weeks, maintaining the sealed container at 2°C to 8°C (standard laboratory refrigeration) is acceptable, provided humidity is strictly controlled. Vials should be stored in desiccated containers equipped with active silica gel packs or under an inert gas blanket (such as argon or nitrogen) when possible. Crucially, before opening any cold-stored vial of 5-Amino-1MQ, researchers must allow the container to equilibrate to ambient room temperature (approximately 20°C to 22°C) for at least 30 to 45 minutes. Opening a cold vial in ambient laboratory air causes immediate condensation of atmospheric moisture onto the dry powder, introducing hydrolytic contamination and introducing measurement errors in analytical balances.

Reconstitution Guidance for Laboratory Research

Reconstitution of 5-Amino-1MQ requires careful consideration of solvent compatibility, target concentration, and downstream biological assay requirements. Unlike hydrophilic signaling peptides, 5-Amino-1MQ exhibits variable solubility depending on the ionic strength and pH of the carrier matrix. For standard stock solutions used in cell culture or biochemical assays, research-grade dimethyl sulfoxide (DMSO) or high-purity sterile water (or physiological saline) may be utilized depending on the specific experimental protocol.

When preparing stock solutions in DMSO, 5-Amino-1MQ rapidly dissolves to form stable, clear solutions at concentrations up to 10–20 mM, making DMSO the preferred solvent for high-concentration master stocks. For aqueous reconstitutions, gentle agitation or mild sonication at room temperature may be required to achieve complete dissolution. Researchers should avoid high-shear vortexing or excessive heating (above 37°C) to accelerate solubility, as elevated thermal energy can catalyze unintended side reactions. All reconstitution procedures should be performed under a laminar flow hood or biological safety cabinet using sterile, non-pyrogenic labware to prevent microbial contamination.

Solution Stability and Freeze-Thaw Prevention

Once reconstituted into liquid stock, 5-Amino-1MQ exhibits a distinct stability profile compared to its solid-state powder. Reconstituted stock solutions prepared in pure DMSO can be partitioned into single-use aliquots and stored at -20°C or -80°C for several months without significant loss of inhibitory potency. Aqueous solutions, however, possess a shorter operational shelf life and should ideally be prepared fresh for each experimental block or utilized within 24 to 48 hours when maintained at 2°C to 8°C.

Repeated freeze-thaw cycles represent one of the primary drivers of compound degradation in solution. Subjecting liquid stocks to fluctuating thermal regimes causes localized concentration gradients, pH shifts, and potential precipitation of the solute. To prevent degradation, researchers should calculate the exact volume required for individual experimental runs and aliquot the master stock accordingly into sterile, low-binding microcentrifuge tubes. Any unused thawed aliquot should be discarded or reserved exclusively for non-quantitative exploratory screening, rather than critical analytical assays.

Mechanistic Context: NNMT Inhibition, NAD+ Dynamics, and Energy Metabolism

Executing precise storage and handling protocols ensures that 5-Amino-1MQ retains high specific activity for evaluating metabolic signaling cascades. NNMT is a key regulatory enzyme situated at the intersection of methionine kinetics, polyamine synthesis, and NAD+ homeostasis. By selectively inhibiting NNMT, 5-Amino-1MQ limits the conversion of nicotinamide into 1-methylnicotinamide (1-MNA). This inhibition preserves the pool of available nicotinamide, allowing the cellular machinery to shunt NAM back into the NAD+ salvage pathway via nicotinamide phosphoribosyltransferase (NAMPT).

Preclinical studies suggest that elevating intracellular NAD+ availability via 5-Amino-1MQ administration yields pronounced downstream effects on mitochondrial output and lipid handling. In vitro models utilizing differentiated adipocytes and skeletal muscle cell lines demonstrate that 5-Amino-1MQ exposure promotes SIRT1 activation, increases mitochondrial biogenesis markers, and accelerates fatty acid oxidation rates. To explore related biological targets governing cellular energy, researchers can examine our analysis on NAD+ precursors and pathways within the broader PX1 research library.

Comparative Analysis: 5-Amino-1MQ vs. Parallel Metabolic Research Compounds

When investigating cellular metabolism, researchers often compare 5-Amino-1MQ against alternative metabolic modulators and mitochondrial-targeted compounds to map specific pathways. While 5-Amino-1MQ operates via direct enzymatic inhibition of cytosolic NNMT to elevate NAD+ levels, compounds such as the mitochondrial-derived peptide MOTS-c function primarily by activating the AMPK pathway and modulating nuclear gene expression during metabolic stress. Similarly, the synthetic nucleotide analog AICAR acts as a direct AMP-mimetic to stimulate AMPK without modulating the methyl donor pool or directly inhibiting NNMT.

In contrast to upstream enzymatic inhibitors or energy-sensing agonists, cardiolipin-targeted peptides like SS-31 preserve mitochondrial function by stabilizing the inner mitochondrial membrane architecture and reducing electron leak rather than altering metabolic substrate availability. Understanding these distinct mechanisms—and maintaining rigorous chemical purity across all tested agents—allows laboratories to conduct precise comparative studies evaluating fat-metabolism research, mitochondrial respiration, and cellular longevity signaling.

Cold Chain Logistics and Packaging Standards at PX1 Research

To ensure that laboratory reagents arrive at research facilities with uncompromised integrity, PX1 Research implements rigorous cold-chain management and packaging protocols. Every batch of 5-Amino-1MQ synthesized for research use undergoes immediate post-purification packaging into vacuum-sealed, light-protected amber vials equipped with tamper-evident seals. This packaging architecture shields the dry reagent from atmospheric oxygen, humidity, and photo-degradation during transit and storage.

Orders fulfilled by PX1 Research are dispatched directly from our optimized logistics facilities located in California and Arizona. We offer same-day shipping for orders placed Monday through Friday before cut-off times, utilizing temperature-controlled, insulated packaging designed to cushion reagents against environmental temperature spikes during transit. Institutional accounts seeking bulk procurement for large-scale study panels can access specialized handling protocols through our wholesale laboratory portal.

Quality Assurance: HPLC, MS, and Analytical Verification

Assay reproducibility depends fundamentally on reagent purity and batch-to-batch consistency. PX1 Research subjects every lot of 5-Amino-1MQ to independent third-party analytical verification before release. Testing is performed in ISO 17025 accredited laboratories using High-Performance Liquid Chromatography (HPLC) to confirm chemical purity levels exceeding 98%, alongside Mass Spectrometry (MS) to verify precise molecular structure and formula weight.

In addition to structural identity and chromatographic purity, PX1 Research performs rigorous endotoxin testing on all laboratory compounds to ensure compliance with strict preclinical research thresholds. Every shipment includes access to a lot-specific Certificate of Analysis (COA), allowing principal investigators to verify quantitative analytical parameters prior to introducing reagents into sensitive cell culture systems or animal models. To review our complete catalog of analytical-grade compounds, visit the PX1 research peptides directory.

Laboratory Safety, Biohazard Handling, and Disposal Guidance

5-Amino-1MQ is a potent small-molecule enzyme inhibitor intended exclusively for laboratory research use only by qualified scientific personnel. When handling dry or reconstituted 5-Amino-1MQ, laboratory personnel must adhere to Standard Operating Procedures (SOPs) appropriate for chemical reagents of unknown biological hazard. Standard Personal Protective Equipment (PPE)—including nitrile gloves, protective eyewear, lab coats, and closed-toe footwear—must be worn at all times.

Reconstitution and weighing procedures should be conducted within a certified chemical fume hood or class II biological safety cabinet to prevent accidental inhalation of fine particulate powder or aerosolized liquid droplets. Spills should be contained immediately using absorbent materials and neutralized with appropriate laboratory cleaning agents. All unused compound, contaminated packaging, and liquid waste streams must be disposed of in accordance with institutional biosafety guidelines and local, state, and federal hazardous waste regulations.

Frequently Asked Questions

What is the recommended storage temperature for dry 5-Amino-1MQ powder?

For long-term storage exceeding 30 days, dry 5-Amino-1MQ powder should be stored at -20°C to -80°C in a desiccated, light-protected container. For short-term storage under four weeks, maintaining the sealed container at 2°C to 8°C is acceptable.

How should reconstituted 5-Amino-1MQ solutions be stored?

Reconstituted stock solutions prepared in DMSO should be divided into single-use aliquots and stored at -20°C or -80°C to prevent degradation. Aqueous solutions are less stable and should be prepared fresh or used within 24 to 48 hours at 2°C to 8°C.

Which solvents are best for solubilizing 5-Amino-1MQ for laboratory assays?

Research-grade DMSO is the preferred solvent for creating high-concentration master stocks (up to 10–20 mM). Sterile water or physiological saline can be used for working solutions depending on the specific requirements of the in vitro or animal study protocol.

Why must cold vials of 5-Amino-1MQ equilibrate to room temperature before opening?

Opening a cold vial in ambient laboratory air causes immediate condensation of atmospheric moisture onto the powder. This moisture contamination can induce chemical degradation and alter the mass accuracy of the compound during weighing.

How does PX1 Research package 5-Amino-1MQ to ensure stability during transit?

PX1 Research packages 5-Amino-1MQ in light-protected amber vials sealed under vacuum or inert gas. Orders are shipped in insulated containers from California and Arizona facilities with same-day dispatch M–F to minimize transit exposure.

What quality verification documentation is provided with PX1 5-Amino-1MQ?

Every lot of 5-Amino-1MQ is supplied with a lot-specific Certificate of Analysis (COA) from an ISO 17025 accredited laboratory, verifying HPLC purity (>98%), mass spectrometry identity, and endotoxin compliance.

Can 5-Amino-1MQ undergo multiple freeze-thaw cycles after reconstitution?

No. Repeated freeze-thaw cycles can cause chemical degradation and solute precipitation. Stock solutions should be partitioned into single-use aliquots immediately after reconstitution.

Is 5-Amino-1MQ approved for human consumption or therapeutic use?

No. 5-Amino-1MQ is a research compound synthesized strictly for in vitro and preclinical laboratory research use only. It is not for human or animal therapeutic, clinical, or diagnostic use.

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.